Evidence map›Paper›PMID 39010141›Full record

ReviewItalian journal of pediatrics2024

Risk factors for drug hypersensitivity reactions in children.

Francesca Mori, Francesca Saretta, Sara Riscassi, Silvia Caimmi, Paolo Bottau, Lucia Liotti, Fabrizio Franceschini, Annamaria Bianchi, Rocco Luigi Valluzzi, Giuseppe Crisafulli and 1 more

Abstract readReview
In one paragraph

Review in Italian journal of pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. A protocol proposal for safe dental anaesthesia in paediatric patients with allergic backgrounds: insights from a case series of allergic patients.European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2026
    Article
  2. Clinical and behavioral determinants in pediatric non-immediate drug hypersensitivity: Low confirmation but persistent avoidance.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Article
  3. Updates in Pediatric Drug Allergy.Current allergy and asthma reports · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Francesca MoriAllergy Unit, Meyer Children's Hospital IRCCS, 50139, Florence, Italy.
Francesca SarettaDipartimento Materno-Infantile, SC Pediatria, Ospedale Latisana-Palmanova, Azienda Sanitaria Universitaria Friuli Centrale, 33100, Udine, Italy.
Sara RiscassiUOC Di Pediatria, Ospedale Bolzano, Azienda Sanitaria Dell'Alto Adige, Bolzano, 39100, Italy.
Silvia CaimmiSC Di Pediatria, Fondazione IRCSS Policlinico San Matteo, 27100, Pavia, Italy.
Paolo BottauUOC Di Pediatria E Neonatologia, Ospedale Imola (BO), Imola, 40026, Italy.
Lucia LiottiUOC Pediatria, Azienda Ospedaliero-Universitaria "Ospedali Riuniti", 60100, Ancona, Italy.
Fabrizio FranceschiniPrivate Practice in Allergy, 60100, Ancona, Italy.
Annamaria BianchiUOC Pediatria, Azienda Ospedaliera San Camillo Forlanini, 00152, Rome, Italy.
Rocco Luigi ValluzziTranslational Research in Pediatric Specialties Area, Division of Allergy, Bambino Gesù Children's Hospital, IRCCS, 00165, Rome, Italy.
Giuseppe CrisafulliDipartimento Materno-Infantile, UOC Pediatria, University of Messina, Messina, 98122, Italy.
Carlo CaffarelliDepartment of Medicine and Surgery, Clinica Pediatrica, Azienda Ospedaliera-Universitaria, University of Parma, 43123, Parma, Italy. carlo.caffarelli@gmail.com.ORCID http://orcid.org/0000-0001-7710-6995

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug hypersensitivity reactions are common in children. Risk factors predisposing to IgE-mediated drug allergies and delayed drug reactions are a matter of debate. Gender, age, previous reactions to the same drug or to another drug, reduced drug metabolism, chronic diseases, polypharmacy, drug doses are linked with the onset of hypersensitivity reactions in some children. Novel advances in genetic polymorphisms can rapidly change the approach to the prevention of reactions since gene testing can be a useful screening test for severe cutaneous adverse reactions. Viral infections may act as cofactors in susceptible individuals. Polypharmacy, high doses, repeated doses and parental route of administration are also risk factors. Clinicians should take into account risk factors to allow the risk-benefit balance to be maintained.

Indexed as

Drug HypersensitivityChildHumansRisk FactorsChildrenDrug allergyHypersensitivity reactionsRisk factorsSevere cutaneous adverse reaction

Identifiers

PMID39010141
PMCPMC11247891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.